» Articles » PMID: 29773031

DNA Vaccines - A Modern Gimmick or a Boon to Vaccinology?

Overview
Publisher Begell House
Date 2018 May 19
PMID 29773031
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The reports in 1993 that naked DNA encoding viral genes conferred protective immunity came as a surprise to most vaccinologists. This review analyses the expanding number of examples where plasmid DNA induces immune responses. Issues such as the type of immunity induced, mechanisms of immune protection, and how DNA vaccines compare with other approaches are emphasized. Additional issues discussed include the likely means by which DNA vaccines induce CTL, how the potency and type of immunity induced can be modified, and whether DNA vaccines represent a practical means of manipulating unwanted immune response occurring during immunoinflammatory diseases. It seems doubtful if DNA vaccines will replace currently effective vaccines, but they may prove useful for prophylactic use against some agents that at present lack an effective vaccine. DNA vaccines promise to be valuable to manipulate the immune response in situations where responses to agents are inappropriate or ineffective.

Citing Articles

Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches.

Fatemi N, Mirbahari S, Tierling S, Sanjabi F, Shahrivari S, AmeliMojarad M Dig Dis Sci. 2025; .

PMID: 39869166 DOI: 10.1007/s10620-024-08774-2.


HCV Core/NS3 Protein Immunization with "N-Terminal Heat Shock gp96 Protein (rNT (gp96))" Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice.

Hajikhezri Z, Roohvand F, Maleki M, Shahmahmoodi S, Amirzargar A, Keshavarz A Vaccines (Basel). 2021; 9(3).

PMID: 33802466 PMC: 7999198. DOI: 10.3390/vaccines9030215.


Phages in vaccine design and immunity; mechanisms and mysteries.

de Vries C, Chen Q, Demirdjian S, Kaber G, Khosravi A, Liu D Curr Opin Biotechnol. 2020; 68:160-165.

PMID: 33316575 PMC: 8137517. DOI: 10.1016/j.copbio.2020.11.002.


Regulatory Considerations on the Development of mRNA Vaccines.

Naik R, Peden K Curr Top Microbiol Immunol. 2020; 440:187-205.

PMID: 32638114 DOI: 10.1007/82_2020_220.